Markets Stocks Economy Crypto Earnings Banking Energy
Home› Markets› Feature
Markets · Exclusive

European ADRs slip 0.7% as biotech and blue chips drag

European ADRs slip 0.7% as biotech and blue chips drag
Markets · 2026
Photo · Eleanor Whitfield for Daily Digest Invest
By Eleanor Whitfield Markets Editor-in-Chief Nov 19, 2026 4 min read

European companies that trade on US exchanges as American depositary receipts (ADRs) slipped late Thursday morning, with the S&P Europe Select ADR Index falling 0.70% to 1,787.15. The decline was driven by a few sharp single-stock drops that outweighed smaller gains elsewhere, pointing to a broad risk-off tone rather than weakness in any one sector.

What are ADRs and why do they matter?

ADRs are certificates that allow US investors to buy shares of foreign companies on American exchanges, during US market hours. They are essentially a US-listed proxy for a foreign stock, with each ADR representing a certain number of underlying shares. This makes it easier for everyday investors to diversify internationally without dealing with foreign exchanges or currency conversions.

On Thursday, the day's action was mixed. A couple of smaller health care names moved higher: EDAP TMS, a French medical device maker, gained 3.7%, and DBV Technologies, a French biotech, rose 3.4%. But the decliners told a different story. Evaxion, a Danish biotech, plunged 11%, while Endava, a UK-listed software firm, fell 5.9%.

More importantly for the broader market, several widely held European giants also declined. Anheuser-Busch InBev fell 3.2%, Unilever dropped 2.3%, SAP lost 2.1%, and British American Tobacco slipped 2.5%. These blue-chip losses helped pull the index down even as Lloyds and Barclays edged higher and BP was little changed.

Why the ADR index matters for European markets

ADRs aren't just a US wrapper around European shares; they often act as the live price when Europe's cash markets are closed. Market makers and arbitrage desks typically keep an ADR aligned with its home-listed share price after adjusting for currency, using hedges and cross-market trading. So when big, heavily owned names like Anheuser-Busch InBev, Unilever, SAP, and British American Tobacco fall during US hours, that weakness can translate into a bigger-than-expected jump down, or “gap,” at the next local-market open.

In other words, the 0.70% index drop may understate how much reopening risk sits in those specific stocks. For investors holding European shares directly, Thursday's ADR action could be a preview of Friday's trading in Europe.

The move comes amid a broader backdrop of uncertainty in global markets. European stocks have been volatile recently, with concerns about inflation, interest rates, and geopolitical tensions weighing on sentiment. For example, European stocks have slid on worries about a copper slump and jitters around a major tech IPO. Meanwhile, European ADRs have already seen several down days, with SAP and BHP leading losses in recent sessions.

What it means for investors

For everyday investors, the ADR index is a useful gauge of how European markets are likely to open. If you own US-listed ADRs, Thursday's decline means your holdings may have lost value. But it's important to remember that ADR prices also reflect currency movements, so a weaker dollar can sometimes offset stock declines.

The sharp drops in smaller biotechs like Evaxion and Endava are reminders that individual stocks can be volatile, especially in the biotech and tech sectors. These companies often have higher risk profiles, and their ADRs can swing more than blue chips. For most investors, diversification across sectors and regions remains a key strategy to manage such volatility.

Looking ahead, investors will likely watch whether the weakness in European blue chips continues into the next trading session. If the ADR declines translate into a lower open in Europe, it could signal broader risk aversion. On the other hand, if the market stabilizes, the dip might be seen as a buying opportunity for those with a longer-term horizon.

As always, it's wise to keep an eye on the broader economic data and corporate earnings that can move markets. For instance, eurozone inflation ticking up could influence central bank policy and affect European equities. And with major IPOs like Anthropic on the horizon, market sentiment could shift quickly.

In the meantime, Thursday's ADR slide serves as a reminder that global markets are interconnected, and what happens in US trading hours can have ripple effects across the Atlantic.

More from this story

Next article · Don't miss

Amer Sports sales surge 29% but stock lags; buyback signals value

Arc'teryx and Salomon owner Amer Sports is growing fast—sales up 29% this year—yet its stock is down 17%. With a $1 billion buyback and improving margins, the market may be missing the story.

Read the story →
Amer Sports sales surge 29% but stock lags; buyback signals value